Director Shareholding
August 04 2003 - 12:27PM
UK Regulatory
RNS Number:3095O
CeNeS Pharmaceuticals PLC
04 August 2003
CeNeS Pharmaceuticals plc ("the Company")
Directors' Shareholding
The Company today announces that, on 1 August 2003, awards of options over
ordinary shares of 10p in the Company ("Ordinary Shares") were made to the
following Directors under a long term incentive plan, the CeNeS Pharmaceuticals
Executive Share Incentive plan:
Director: Neil Clark
Number of Ordinary Shares over which options granted: 1,647,500
Exercise price in pence: Nil Cost
Date of grant: 1.08.03
Period of exercise: 3 years
Total number of Ordinary Shares over which options held following this
notification: 3,140,346
Director : Alan Goodman
Number of Ordinary Shares over which options granted: 1,299,375
Exercise price in pence: Nil Cost
Date of grant: 1.08.03
Period of exercise: 3 years
Total number of Ordinary Shares over which options held following this
notification: 4,378,287
The option awards announced today are subject to performance targets related to
the Ordinary Share price performance over three years. These targets must be met
or exceeded before the Executive Options may be exercised.
4 August 2003
For further information:
Neil Clark, CeNeS Pharmaceuticals plc - 01223 266466
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUSUNRONRWRAR